마이크로바이옴 샘플 조제 기술 시장 - 세계 산업 규모, 점유율, 동향, 기회와 예측 : 제품별, 워크플로우별, 용도별, 질환 유형별, 최종사용자별, 지역별＆경쟁(2021-2031년)

Microbiome Sample Preparation Technology Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Workflow, By Application, By Disease Type, By End User, By Region & Competition, 2021-2031F

US $ 4,500 ￦ 6,792,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,302,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 12,076,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 마이크로바이옴산풀 조제 기술 시장은 2025년 2억 5,000만 달러에서 2031년까지 3억 7,000만 달러로 성장하고, CAGR 6.75%를 나타낼 것으로 예측됩니다.

이 분야는 다양한 생물학적 매트릭스에서 고품질의 미생물 핵산을 분리, 정제, 안정화하여 후속 분석에 제공하기 위한 전용 시약, 키트, 자동화 장비를 포함합니다. 성장의 주요 원동력은 생활습관 관련 만성질환 발생률 증가와 정확한 미생물 프로파일링이 필요한 개인 맞춤형 치료에 대한 수요 증가입니다. 또한, 산업계와의 협력 강화로 연구 역량이 향상되고 있습니다. 예를 들어, 피스토이아 얼라이언스는 2024년 치료법 발견을 촉진하기 위해 마이크로바이옴을 통한 약물 대사 데이터베이스 구축 등 경쟁 전 단계에서 200개 이상의 회원 조직과 협력했다고 보고했습니다.

시장 개요
예측 기간	2027-2031년
시장 규모 : 2025년	2억 5,000만 달러
시장 규모 : 2031년	3억 7,000만 달러
CAGR : 2026년-2031년	6.75%
가장 성장이 빠른 부문	소모품
최대 시장	북미

이러한 상승 추세에도 불구하고 업계는 샘플 수집 및 처리에 대한 보편적으로 표준화된 프로토콜의 부족으로 인해 큰 장벽에 직면해 있습니다. 미생물 샘플의 본질적인 다양성은 서로 다른 연구 간에 데이터 불일치 및 추출 편향이 빈번하게 발생하여 규제 검증 및 상업적 확장성에 필요한 재현성을 저해하는 결과를 초래합니다.

시장 성장 촉진요인

마이크로바이옴 연구에 대한 자금 조달과 투자가 급증하면서 세계 마이크로바이옴 시료 준비 기술 시장에 중요한 촉매제가 되고 있습니다. 장 건강과 전신 건강의 연관성이 밝혀지면서 워크플로우의 표준화와 새로운 치료법 개발을 목표로 하는 생명공학 기업들에 대한 자본 투입이 증가하고 있습니다. 이 자금 지원을 통해 기업은 샘플 수집 및 추출 절차를 최적화하고 임상 검증에 필요한 고정밀 데이터 생성을 보장할 수 있습니다. 이러한 추세는 2025년 4월 시리즈 B 라운드에서 452만 달러를 조달하고 마이크로바이옴 데이터 및 기술 제공 확대를 발표한 Biohm Technologies에서 두드러지게 나타나고 있습니다. 이는 복잡한 매트릭스를 관리할 수 있는 고급 키트 개발을 촉진하고 있습니다.

또한, 차세대 시퀀싱 기술의 기술적 혁신은 현대 플랫폼의 높은 처리량과 고감도에 대응하는 업스트림 공정 솔루션에 대한 수요를 창출하여 시장 확대를 가속화하고 있습니다. 시퀀싱 툴이 저비용화, 고데이터 수율화가 진행될수록 처리의 병목현상이 발생하며, 이를 해소하기 위해서는 자동화되고 효율적인 시료 전처리 시스템이 필수적입니다. 주요 기업들의 견조한 재무 실적이 이러한 추세를 뒷받침하고 있습니다. 옥스포드 나노포어 테크놀로지스는 2025년 6월 중간 결산에서 환율 변동 영향을 제외한 매출이 28.0% 증가했다고 보고했으며, 일루미나는 2025년 10월 분기 매출이 10억 8,000만 달러에 달했다고 밝혔습니다. 이러한 수치는 지속적으로 확대되고 있는 유전체 프로파일링 생태계를 지원하는 데 있어 신뢰할 수 있는 시료 전처리가 중요한 역할을 하고 있음을 강조합니다.

시장의 과제

세계 마이크로바이옴 시료 준비 기술 시장이 직면한 주요 장벽은 시료 수집 및 조사 방법에 대한 보편적인 표준화가 부족하다는 점입니다. 이러한 불일치는 데이터의 무결성과 재현성을 저해하는 심각한 병목현상을 야기합니다. 실험실에서 서로 다른 추출 키트와 안정화 기법을 사용하게 되면, 얻어진 미생물 프로파일이 크게 달라져 진정한 생물학적 신호와 기술적 아티팩트를 구분하기가 어려워집니다. 피스토리아 얼라이언스의 2024년 조사에 따르면, 생명과학 전문가의 48%는 메타데이터 표준화의 부족을 연구 개발에서 실험 데이터의 효과적인 활용을 저해하는 주요 장벽으로 인식하고 있으며, 이는 임상 바이오마커 검증에 필요한 연구 간 비교를 방해하고 있다고 답했습니다.

그 결과, 이러한 변동성은 규제 당국의 승인과 상업화 노력을 지연시키고 시장 발전을 저해하고 있습니다. 규제 당국은 마이크로바이옴 기반 진단 및 치료법의 안전성과 유효성을 확인하기 위해 강력하고 재현 가능한 데이터를 요구하고 있지만, 통일된 프로토콜이 없기 때문에 제조업체들은 일관성을 입증하는 데 어려움을 겪고 있습니다. 이러한 불확실성은 투자 의욕을 떨어뜨리고, 임상 환경에서 시료 전처리 기술의 채택을 지연시켜 궁극적으로 시장의 전반적인 수익 잠재력을 제한하고 있습니다.

시장 동향

저바이오매스 환경을 위한 전용 추출 솔루션의 개발은 피부, 혈액 등 미생물 함량이 극히 적은 시료 처리에 따른 문제를 해결함으로써 시장을 변화시키고 있습니다. 기존 키트는 이러한 매트릭스에서 숙주 DNA와 미생물 DNA의 비율이 높다는 문제에 직면하는 경우가 많아, 고품질 데이터를 확보하기 위해 고감도 및 최적화된 프로토콜이 필요합니다. 이러한 기술적 요구사항은 추출 효율 향상에 초점을 맞춘 전략적 제휴를 촉진하고 있습니다. 예를 들어, 2024년 11월 Qiagen과 맥길대학교는 저바이오매스 샘플에 특화된 방법을 공동 개발하는 협업을 발표하며 18억 달러 규모의 북미 마이크로바이옴 연구 부문의 니즈에 대한 대응 강화를 목표로 하고 있습니다.

동시에, 기존의 벌크 시퀀싱에서 간과하기 쉬운 불균일성을 밝히기 위해 단일 세포 마이크로유체 기술을 이용한 단일 세포 마이크로바이옴 조성이 증가하고 있습니다. 마이크로플루이딕스 방울 내에서 개별 박테리아를 분리함으로써, 이 플랫폼은 복잡한 군집 내에서 균주별 유전자 발현과 대사 기능을 정밀하게 매핑할 수 있습니다. 2024년 12월 신기술 관련 기사에서 다룬 바와 같이, M20 Genomics는 자사의 VITA 단일 세포 전사체 플랫폼이 전 세계적으로 7,000개 이상의 미생물 샘플을 처리했다고 밝혔습니다. 이는 다양한 종에 걸친 기능적 차이를 구별하기 위한 이러한 워크플로우의 확장성과 빠른 보급을 보여줍니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 마이크로바이옴산풀 조제 기술 시장 전망

제6장 북미의 마이크로바이옴산풀 조제 기술 시장 전망

제7장 유럽의 마이크로바이옴산풀 조제 기술 시장 전망

제8장 아시아태평양의 마이크로바이옴산풀 조제 기술 시장 전망

제9장 중동 및 아프리카의 마이크로바이옴산풀 조제 기술 시장 전망

제10장 남미의 마이크로바이옴산풀 조제 기술 시장 전망

제11장 시장 역학

제12장 시장 동향과 발전

제13장 세계의 마이크로바이옴산풀 조제 기술 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

제15장 경쟁 구도

제16장 전략적 제안

제17장 회사 소개 및 면책조항

LSH

영문 목차

영문목차

The Global Microbiome Sample Preparation Technology Market is projected to expand from USD 0.25 Billion in 2025 to USD 0.37 Billion by 2031, registering a CAGR of 6.75%. This sector encompasses specialized reagents, kits, and automated instrumentation designed to isolate, purify, and stabilize high-quality microbial nucleic acids from various biological matrices for subsequent analysis. Growth is primarily propelled by the rising incidence of chronic lifestyle-related conditions and the growing need for personalized medical treatments that require accurate microbial profiling. Furthermore, enhanced industrial cooperation is strengthening research capacities; for instance, the Pistoia Alliance reported in 2024 that it coordinated with over 200 member organizations on pre-competitive initiatives, such as creating a microbiome-mediated drug metabolism database to facilitate therapeutic discovery.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 0.25 Billion
Market Size 2031	USD 0.37 Billion
CAGR 2026-2031	6.75%
Fastest Growing Segment	Consumables
Largest Market	North America

Despite this upward trend, the industry faces a substantial hurdle due to the absence of universally standardized protocols for sample collection and processing. The intrinsic diversity of microbial samples frequently leads to inconsistent data and extraction biases across different studies, which compromises the reproducibility needed for regulatory validation and commercial scalability.

Market Driver

The surge in funding and investment for microbiome research serves as a crucial catalyst for the Global Microbiome Sample Preparation Technology Market. As the connection between gut health and systemic well-being becomes clearer, capital is increasingly directed toward biotechnology firms aiming to standardize workflows and create new therapeutic formulations. This financial support enables companies to optimize sample collection and extraction procedures, ensuring the generation of high-fidelity data necessary for clinical validation. This trend is exemplified by Biohm Technologies, which announced in April 2025 that it had raised $4.52 million in a Series B round to broaden its microbiome data and technology offerings, thereby fueling the development of advanced kits capable of managing complex matrices.

Additionally, technological breakthroughs in Next-Generation Sequencing are accelerating market expansion by creating a need for upstream solutions that align with the high throughput and sensitivity of contemporary platforms. As sequencing tools evolve to offer lower costs and higher data yields, they create processing bottlenecks that can only be alleviated by automated, efficient sample preparation systems. The strong financial performance of key players highlights this dynamic; Oxford Nanopore Technologies reported a 28.0% constant currency revenue increase in its interim results for the period ending June 2025, while Illumina posted quarterly revenue of $1.08 billion in October 2025. These figures underscore the essential role of reliable sample preparation in supporting the growing genomic profiling ecosystem.

Market Challenge

The primary obstacle facing the Global Microbiome Sample Preparation Technology Market is the lack of universal standardization regarding sample collection and processing methodologies. This inconsistency creates a severe bottleneck by undermining data integrity and reproducibility; when laboratories employ different extraction kits or stabilization methods, the resulting microbial profiles often vary significantly, making it difficult to differentiate between genuine biological signals and technical artifacts. According to a 2024 survey by the Pistoia Alliance, 48% of life science experts identified the lack of metadata standardization as a major impediment to the effective use of experimental data in research and development, preventing the cross-study comparisons required to validate clinical biomarkers.

Consequently, this variability impedes market progress by stalling regulatory approvals and commercialization efforts. Regulatory authorities demand robust, reproducible data to confirm the safety and efficacy of microbiome-based diagnostics and treatments, yet manufacturers struggle to prove this consistency without unified protocols. This uncertainty discourages investment and retards the adoption of sample preparation technologies within clinical environments, ultimately restricting the market's overall revenue potential.

Market Trends

The development of specialized extraction solutions for low-biomass environments is transforming the market by resolving difficulties associated with processing samples containing minimal microbial content, such as skin and blood. Conventional kits often face challenges with high host-to-microbial DNA ratios in these matrices, creating a need for sensitive, optimized protocols to secure high-quality data. This technical requirement is spurring strategic partnerships focused on improving extraction efficiency; for example, in November 2024, Qiagen and McGill University announced a collaboration to co-develop methods tailored for low-biomass samples, aiming to better address the needs of the $1.8 billion North American microbiome research sector.

Concurrently, the utilization of microfluidic technologies for single-cell microbiome preparation is increasing as researchers strive to uncover heterogeneity often missed by traditional bulk sequencing. By isolating individual bacteria within microfluidic droplets, these platforms facilitate the precise mapping of strain-specific gene expression and metabolic functions within complex communities. As highlighted in a December 2024 article on emerging technologies, M20 Genomics revealed that its VITA single-cell transcriptome platform has processed over 7,000 microbial samples worldwide, illustrating the scalability and rapid uptake of these workflows to distinguish functional variations across diverse species.

Key Market Players

• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Zymo Research
• Molzym
• Omega Bio-tek
• Promega
• PerkinElmer
• New England Biolabs
• Kapa Biosystems

Report Scope

In this report, the Global Microbiome Sample Preparation Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Sample Preparation Technology Market, By Product

• Instruments
• Consumables

Microbiome Sample Preparation Technology Market, By Workflow

• Sample Extraction/Isolation
• Sample Quantification
• Quality Control
• Fragmentation
• Library Preparation
• Target Enrichment
• Library Quantification
• Pooling

Microbiome Sample Preparation Technology Market, By Application

• DNA Sequencing
• Whole-Genome Sequencing
• RNA Sequencing
• Methylation Sequencing
• Metagenomics
• Single Cell Sequencing
• Others

Microbiome Sample Preparation Technology Market, By Disease Type

• Autoimmune Disorder
• Cancer
• Gastrointestinal Disorders
• Others

Microbiome Sample Preparation Technology Market, By End User

• Pharmaceutical & Biotechnology
• Diagnostic Labs
• Others

Microbiome Sample Preparation Technology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Sample Preparation Technology Market.

Available Customizations:

Global Microbiome Sample Preparation Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Sample Preparation Technology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables)
  • 5.2.2. By Workflow (Sample Extraction/Isolation, Sample Quantification, Quality Control, Fragmentation, Library Preparation, Target Enrichment, Library Quantification, Pooling)
  • 5.2.3. By Application (DNA Sequencing, Whole-Genome Sequencing, RNA Sequencing, Methylation Sequencing, Metagenomics, Single Cell Sequencing, Others)
  • 5.2.4. By Disease Type (Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology, Diagnostic Labs, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Microbiome Sample Preparation Technology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Workflow
  • 6.2.3. By Application
  • 6.2.4. By Disease Type
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microbiome Sample Preparation Technology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Disease Type
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Microbiome Sample Preparation Technology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Disease Type
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Microbiome Sample Preparation Technology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Disease Type
      • 6.3.3.2.5. By End User

7. Europe Microbiome Sample Preparation Technology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Workflow
  • 7.2.3. By Application
  • 7.2.4. By Disease Type
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microbiome Sample Preparation Technology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Disease Type
      • 7.3.1.2.5. By End User
  • 7.3.2. France Microbiome Sample Preparation Technology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Disease Type
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Microbiome Sample Preparation Technology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Disease Type
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Microbiome Sample Preparation Technology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Disease Type
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Microbiome Sample Preparation Technology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Disease Type
      • 7.3.5.2.5. By End User

8. Asia Pacific Microbiome Sample Preparation Technology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Workflow
  • 8.2.3. By Application
  • 8.2.4. By Disease Type
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microbiome Sample Preparation Technology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Disease Type
      • 8.3.1.2.5. By End User
  • 8.3.2. India Microbiome Sample Preparation Technology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Disease Type
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Microbiome Sample Preparation Technology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Disease Type
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Microbiome Sample Preparation Technology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Disease Type
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Microbiome Sample Preparation Technology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Disease Type
      • 8.3.5.2.5. By End User

9. Middle East & Africa Microbiome Sample Preparation Technology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Workflow
  • 9.2.3. By Application
  • 9.2.4. By Disease Type
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microbiome Sample Preparation Technology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Disease Type
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Microbiome Sample Preparation Technology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Disease Type
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Microbiome Sample Preparation Technology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Disease Type
      • 9.3.3.2.5. By End User

10. South America Microbiome Sample Preparation Technology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Workflow
  • 10.2.3. By Application
  • 10.2.4. By Disease Type
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microbiome Sample Preparation Technology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Disease Type
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Microbiome Sample Preparation Technology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Disease Type
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Microbiome Sample Preparation Technology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Disease Type
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microbiome Sample Preparation Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. QIAGEN
• 15.3. Thermo Fisher Scientific
• 15.4. Zymo Research
• 15.5. Molzym
• 15.6. Omega Bio-tek
• 15.7. Promega
• 15.8. PerkinElmer
• 15.9. New England Biolabs
• 15.10. Kapa Biosystems

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료